Colombian congressman Hernando José Padaui has submitted a proposal before the House of Representatives, dubbed the ‘Anti-Ibuprofen Law’, which would force public medicine providers and insurance to provide only originally branded medication to patients, banning the use of generic alternatives. The proposal has been soundly critcized by Colombia’s pharmaceutical sector, with billions of dollars at stake.
Congressman Padaui has defended his proposal, claiming it seeks to boost competition and break up the monopolies of a few pharmaceuticals by promoting the development of new patent drugs and increasing both supply and demand, helping to offset foreseen rises to public spending as a result.
Cesar Burgos Alarcón, president of the Colombian Association of Scientific Societies, expressed his concern over the proposal’s principal mechanism, which would restrict doctors’ ability to prescribe generic alternatives to patients, justified by an assumed reduction in quality when compared to original formulas as the tradeoff for lower prices. “We believe that, beyond the economic impact that could be felt, the fundamental fact lies in the placement of constraints to the autonomy of medical practitioners to prescribe medication, as enshrined in the Legal Statutes, as an element which guarantees the basic right to healthcare.”
Full Content: Vanguardia
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Uruguayan Antitrust Scrutiny Puts Major Meatpacking Deal Between Marfrig and Minerva on Hold
May 19, 2024 by
CPI
Alaska Airlines Seeks Dismissal of Consumer Lawsuit Over $1.9 Billion Hawaiian Airlines Buy
May 19, 2024 by
CPI
Idaho Attorney General Orders Split of Kootenai Health and Syringa Hospital
May 19, 2024 by
CPI
Court Rejects T-Mobile’s Appeal Bid in Antitrust Case Over Sprint Merger
May 19, 2024 by
CPI
Google Requests Judge, Not Jury, to Decide on Antitrust Case
May 19, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI